1. Home
  2. MGRC vs SRPT Comparison

MGRC vs SRPT Comparison

Compare MGRC & SRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo McGrath RentCorp

MGRC

McGrath RentCorp

HOLD

Current Price

$109.68

Market Cap

2.8B

ML Signal

HOLD

Logo Sarepta Therapeutics Inc. (DE)

SRPT

Sarepta Therapeutics Inc. (DE)

HOLD

Current Price

$17.12

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGRC
SRPT
Founded
1979
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.5B
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
MGRC
SRPT
Price
$109.68
$17.12
Analyst Decision
Buy
Hold
Analyst Count
2
29
Target Price
$141.50
$25.85
AVG Volume (30 Days)
247.6K
2.7M
Earning Date
04-29-2026
05-06-2026
Dividend Yield
1.67%
N/A
EPS Growth
N/A
N/A
EPS
1.10
2.88
Revenue
$944,235,000.00
$2,198,237,000.00
Revenue This Year
$4.69
N/A
Revenue Next Year
$4.81
N/A
P/E Ratio
$100.19
$5.78
Revenue Growth
3.65
15.58
52 Week Low
$94.99
$10.42
52 Week High
$128.41
$43.92

Technical Indicators

Market Signals
Indicator
MGRC
SRPT
Relative Strength Index (RSI) 43.09 34.11
Support Level $108.76 $16.09
Resistance Level $111.26 $19.32
Average True Range (ATR) 2.62 1.14
MACD -0.54 -0.48
Stochastic Oscillator 22.62 8.24

Price Performance

Historical Comparison
MGRC
SRPT

About MGRC McGrath RentCorp

McGrath RentCorp is a diversified business-to-business rental company with three rental divisions: relocatable modular buildings, portable storage containers, and electronic test equipment. It comprises four reportable business segments, namely the Modular Building segment (Mobile Modular), which generates maximum revenue; the Portable Storage segment (Portable Storage); the Electronic Test Equipment segment (TRS-RenTelco); and its classroom manufacturing business (Enviroplex), which sells modular buildings used as classrooms in California. The company generates its revenues mainly from the rental of its equipment under operating leases, with sales of equipment occurring in the normal course of business.

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders. The company has developed approved treatments for Duchenne muscular dystrophy, including EXONDYS 51, VYONDYS 53, AMONDYS 45, and ELEVIDYS, and is advancing additional therapeutic candidates for neuromuscular and other rare diseases. The company operates in one segment: discovering, developing, manufacturing, and delivering therapies to patients with rare diseases.

Share on Social Networks: